Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:33564766  

Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike.

Carl Graham | Jeffrey Seow | Isabella Huettner | Hataf Khan | Neophytos Kouphou | Sam Acors | Helena Winstone | Suzanne Pickering | Rui Pedro Galao | Maria Jose Lista | Jose M Jimenez-Guardeno | Adam G Laing | Yin Wu | Magdalene Joseph | Luke Muir | Weng M Ng | Helen M E Duyvesteyn | Yuguang Zhao | Thomas A Bowden | Manu Shankar-Hari | Annachiara Rosa | Peter Cherepanov | Laura E McCoy | Adrian C Hayday | Stuart J D Neil | Michael H Malim | Katie J Doores
bioRxiv : the preprint server for biology | 2021

The interaction of the SARS-CoV-2 Spike receptor binding domain (RBD) with the ACE2 receptor on host cells is essential for viral entry. RBD is the dominant target for neutralizing antibodies and several neutralizing epitopes on RBD have been molecularly characterized. Analysis of circulating SARS-CoV-2 variants has revealed mutations arising in the RBD, the N-terminal domain (NTD) and S2 subunits of Spike. To fully understand how these mutations affect the antigenicity of Spike, we have isolated and characterized neutralizing antibodies targeting epitopes beyond the already identified RBD epitopes. Using recombinant Spike as a sorting bait, we isolated >100 Spike-reactive monoclonal antibodies from SARS-CoV-2 infected individuals. ≈45% showed neutralizing activity of which ≈20% were NTD-specific. None of the S2-specific antibodies showed neutralizing activity. Competition ELISA revealed that NTD-specific mAbs formed two distinct groups: the first group was highly potent against infectious virus, whereas the second was less potent and displayed glycan-dependant neutralization activity. Importantly, mutations present in B.1.1.7 Spike frequently conferred resistance to neutralization by the NTD-specific neutralizing antibodies. This work demonstrates that neutralizing antibodies targeting subdominant epitopes need to be considered when investigating antigenic drift in emerging variants.

Pubmed ID: 33564766

Associated grants

  • Agency: Wellcome Trust, United Kingdom
  • Agency: Arthritis Research UK, United Kingdom
    Id: FC001061
  • Agency: Medical Research Council, United Kingdom
    Id: MR/R008698/1
  • Agency: NIAID NIH HHS, United States
    Id: U54 AI150472

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


FigTree (tool)

RRID:SCR_008515

A graphical viewer of phylogenetic trees and a program for producing publication-ready figures. It is designed to display summarized and annotated trees produced by BEAST.

View all literature mentions

FlowJo (tool)

RRID:SCR_008520

Software for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.

View all literature mentions

Millipore (tool)

RRID:SCR_008983

An Antibody supplier

View all literature mentions

PhyML (tool)

RRID:SCR_014629

Web phylogeny server based on the maximum-likelihood principle.

View all literature mentions

Vero C1008 (tool)

RRID:CVCL_0574

Cell line Vero C1008 is a Spontaneously immortalized cell line with a species of origin Chlorocebus sabaeus

View all literature mentions

Vero C1008 (tool)

RRID:CVCL_0574

Cell line Vero C1008 is a Spontaneously immortalized cell line with a species of origin Chlorocebus sabaeus

View all literature mentions

HeLa (tool)

RRID:CVCL_0030

Cell line HeLa is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions

HEK293T (tool)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HEK293T (tool)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HEK293-F (tool)

RRID:CVCL_6642

Cell line HEK293-F is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HEK293T/17 (tool)

RRID:CVCL_1926

Cell line HEK293T/17 is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HEK293-F (tool)

RRID:CVCL_6642

Cell line HEK293-F is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions